$55.02−0.29 (−0.52%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Atricure (ATRC) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineGrowing fast: revenue compounds ~18.1%/yr (FY21→FY25), net margin −2.1%.
The four lines that matter · FY21–FY25
Revenue ($M)▲14.9%
534.5
FY21→FY25CAGR +18.1%/yr
Net income ($M)▲74.4%
−11.4
one-off year: see footnoteCAGR —
Free cash flow ($M)▲6381.1%
48.3
FY21→FY25CAGR —
Diluted EPS▲74.7%
−0.24
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+3.7%
46.0mn → 47.8mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.
Capex
$9.1M
−21.0% YoY in FY25 · 1.7% of revenue.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-2¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 75.0% → 75.0%. Net margin -2.1% is below the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 589,803.0 | 534,528.0 | 465,307.0 | 399,245.0 | 330,379.0 | 274,329.0 | ▲14.9% | +18.1% |
Cost of revenue | 137,176.0 | 133,749.0 | 117,783.0 | 98,875.0 | 84,439.0 | 68,469.0 | ▲13.6% | +18.2% |
Gross profit | 452,627.0 | 400,779.0 | 347,524.0 | 300,370.0 | 245,940.0 | 205,860.0 | ▲15.3% | +18.1% |
Research & development | 107,258.0 | 99,209.0 | 96,178.0 | 73,915.0 | 57,337.0 | 48,506.0 | ▲3.2% | +19.6% |
Selling, general & admin | 328,334.0 | 311,017.0 | 291,359.0 | 253,138.0 | 231,272.0 | 204,649.0 | ▲6.7% | +11.0% |
Total operating expenses | 435,592.0 | 410,226.0 | 387,537.0 | 327,053.0 | 288,609.0 | 150,655.0 | ▲5.9% | +28.5% |
Operating incomefeeds ROC rank | 17,035.0 | −9,447.0 | −40,013.0 | −26,683.0 | −42,669.0 | 55,205.0 | ▲76.4% | — |
Other income, net | −838.0 | −716.0 | −3,661.0 | −3,164.0 | −3,529.0 | −4,818.0 | — | — |
Pretax income | 16,197.0 | −10,163.0 | −43,674.0 | −29,847.0 | −46,198.0 | 50,387.0 | ▲76.7% | — |
Income tax | 1,314.0 | 1,285.0 | 1,024.0 | 591.0 | 268.0 | 188.0 | ▲25.5% | +61.7% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | 14,883.0 | −11,448.0 | −44,698.0 | −30,438.0 | −46,466.0 | 50,199.0 | ▲74.4% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 0.30 | −0.24 | −0.95 | −0.66 | −1.02 | 1.09 | ▲74.7% | — |
Diluted shares (mn) | 49.83 | 47.75 | 46.97 | 46.31 | 45.74 | 46.04 | ▲1.7% | +0.9% |
| Margins | ||||||||
Gross margin70th pct in Healthcare | 76.7% | 75.0% | 74.7% | 75.2% | 74.4% | 75.0% | ▲0.3pp | −0.1pp |
Operating margin | 2.9% | −1.8% | −8.6% | −6.7% | −12.9% | 20.1% | ▲6.8pp | −21.9pp |
Net margin46th pct in Healthcare | 2.5% | −2.1% | −9.6% | −7.6% | −14.1% | 18.3% | ▲7.5pp | −20.4pp |
† TTM = trailing four quarters through 2026-09-30.FY25 effective tax rate was −13% vs a −2% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium, and 12 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-19 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Atricure's revenue last fiscal year?
Atricure reported revenue of $534.5M in fiscal 2025, up 14.9% from fiscal 2024.
What was Atricure's net income?
Atricure reported net income of −$11.4M in fiscal 2025, a net margin of −2.1%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

